Filing Details
- Accession Number:
- 0001209191-20-050685
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2020-09-16 16:06:08
- Reporting Period:
- 2020-09-10
- Accepted Time:
- 2020-09-16 16:06:08
- Original Submission Date:
- 2020-09-14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1300699 | Athenex Inc. | ATNX | Pharmaceutical Preparations (2834) | 431985966 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1771886 | A Stephanie Davis | C/O Athenex, Inc. 1001 Main Street, Suite 600 Buffalo NY 14203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-09-10 | 10,000 | $11.35 | 20,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple trades ranging from $11.31 to $11.37. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder full information regarding the number of shares and prices at which the transactions were effected.
- This transaction was previously reported by Ms. Davis. This amendment is being filed to provide the price range for the multiple trades used to calculate the weighted average price.
Billionaire Hedge Funds
